Circulating Tumour Cells in Patients With Peritoneal Metastases

Uppsala University114 enrolled

Overview

This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal cancers that have spread to the peritoneum.

CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Clinical routine. Disease recurrence and overall survival will be the endpoint used.

Study Type

OBSERVATIONAL

Enrollment

114

Conditions

Circulating Tumor Cell Peritoneal Metastases Hyperthermic Intraperitoneal Chemotherapy

Interventions

iCellateDIAGNOSTIC_TEST

New method of circulating tumour cell detection and capture.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Peritoneal metastases being treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Exclusion Criteria: * None

Locations (1)

Akademiska Sjukhuset (Uppsala University hospital)

Uppsala, Sweden

Outcomes

Primary Outcomes

Prognostic value

Prediction of survival and recurrence according to the occurrence of CTCs.

Time frame: 2 year.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.